Global Biological Hemostatic Material Market Research Report 2024(Status and Outlook)
Report Overview:
Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.
The Global Biological Hemostatic Material Market Size was estimated at USD 564.16 million in 2023 and is projected to reach USD 800.28 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.
This report provides a deep insight into the global Biological Hemostatic Material market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biological Hemostatic Material Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biological Hemostatic Material market in any manner.
Global Biological Hemostatic Material Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
Market Segmentation (by Type)
Collagen
Gelatin
Polysaccharides
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biological Hemostatic Material Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.
The Global Biological Hemostatic Material Market Size was estimated at USD 564.16 million in 2023 and is projected to reach USD 800.28 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.
This report provides a deep insight into the global Biological Hemostatic Material market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biological Hemostatic Material Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biological Hemostatic Material market in any manner.
Global Biological Hemostatic Material Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
Market Segmentation (by Type)
Collagen
Gelatin
Polysaccharides
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biological Hemostatic Material Market
- Overview of the regional outlook of the Biological Hemostatic Material Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biological Hemostatic Material Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biological Hemostatic Material
1.2 Key Market Segments
1.2.1 Biological Hemostatic Material Segment by Type
1.2.2 Biological Hemostatic Material Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICAL HEMOSTATIC MATERIAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biological Hemostatic Material Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biological Hemostatic Material Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICAL HEMOSTATIC MATERIAL MARKET COMPETITIVE LANDSCAPE
3.1 Global Biological Hemostatic Material Sales by Manufacturers (2019-2024)
3.2 Global Biological Hemostatic Material Revenue Market Share by Manufacturers (2019-2024)
3.3 Biological Hemostatic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biological Hemostatic Material Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biological Hemostatic Material Sales Sites, Area Served, Product Type
3.6 Biological Hemostatic Material Market Competitive Situation and Trends
3.6.1 Biological Hemostatic Material Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biological Hemostatic Material Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGICAL HEMOSTATIC MATERIAL INDUSTRY CHAIN ANALYSIS
4.1 Biological Hemostatic Material Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICAL HEMOSTATIC MATERIAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOLOGICAL HEMOSTATIC MATERIAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biological Hemostatic Material Sales Market Share by Type (2019-2024)
6.3 Global Biological Hemostatic Material Market Size Market Share by Type (2019-2024)
6.4 Global Biological Hemostatic Material Price by Type (2019-2024)
7 BIOLOGICAL HEMOSTATIC MATERIAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biological Hemostatic Material Market Sales by Application (2019-2024)
7.3 Global Biological Hemostatic Material Market Size (M USD) by Application (2019-2024)
7.4 Global Biological Hemostatic Material Sales Growth Rate by Application (2019-2024)
8 BIOLOGICAL HEMOSTATIC MATERIAL MARKET SEGMENTATION BY REGION
8.1 Global Biological Hemostatic Material Sales by Region
8.1.1 Global Biological Hemostatic Material Sales by Region
8.1.2 Global Biological Hemostatic Material Sales Market Share by Region
8.2 North America
8.2.1 North America Biological Hemostatic Material Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biological Hemostatic Material Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biological Hemostatic Material Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biological Hemostatic Material Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biological Hemostatic Material Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Johnson and Johnson
9.1.1 Johnson and Johnson Biological Hemostatic Material Basic Information
9.1.2 Johnson and Johnson Biological Hemostatic Material Product Overview
9.1.3 Johnson and Johnson Biological Hemostatic Material Product Market Performance
9.1.4 Johnson and Johnson Business Overview
9.1.5 Johnson and Johnson Biological Hemostatic Material SWOT Analysis
9.1.6 Johnson and Johnson Recent Developments
9.2 BD
9.2.1 BD Biological Hemostatic Material Basic Information
9.2.2 BD Biological Hemostatic Material Product Overview
9.2.3 BD Biological Hemostatic Material Product Market Performance
9.2.4 BD Business Overview
9.2.5 BD Biological Hemostatic Material SWOT Analysis
9.2.6 BD Recent Developments
9.3 Baxter
9.3.1 Baxter Biological Hemostatic Material Basic Information
9.3.2 Baxter Biological Hemostatic Material Product Overview
9.3.3 Baxter Biological Hemostatic Material Product Market Performance
9.3.4 Baxter Biological Hemostatic Material SWOT Analysis
9.3.5 Baxter Business Overview
9.3.6 Baxter Recent Developments
9.4 B.Braun
9.4.1 B.Braun Biological Hemostatic Material Basic Information
9.4.2 B.Braun Biological Hemostatic Material Product Overview
9.4.3 B.Braun Biological Hemostatic Material Product Market Performance
9.4.4 B.Braun Business Overview
9.4.5 B.Braun Recent Developments
9.5 Cura Medical
9.5.1 Cura Medical Biological Hemostatic Material Basic Information
9.5.2 Cura Medical Biological Hemostatic Material Product Overview
9.5.3 Cura Medical Biological Hemostatic Material Product Market Performance
9.5.4 Cura Medical Business Overview
9.5.5 Cura Medical Recent Developments
9.6 GELITA MEDICAL
9.6.1 GELITA MEDICAL Biological Hemostatic Material Basic Information
9.6.2 GELITA MEDICAL Biological Hemostatic Material Product Overview
9.6.3 GELITA MEDICAL Biological Hemostatic Material Product Market Performance
9.6.4 GELITA MEDICAL Business Overview
9.6.5 GELITA MEDICAL Recent Developments
9.7 Curasan AG
9.7.1 Curasan AG Biological Hemostatic Material Basic Information
9.7.2 Curasan AG Biological Hemostatic Material Product Overview
9.7.3 Curasan AG Biological Hemostatic Material Product Market Performance
9.7.4 Curasan AG Business Overview
9.7.5 Curasan AG Recent Developments
9.8 Meril Life Sciences
9.8.1 Meril Life Sciences Biological Hemostatic Material Basic Information
9.8.2 Meril Life Sciences Biological Hemostatic Material Product Overview
9.8.3 Meril Life Sciences Biological Hemostatic Material Product Market Performance
9.8.4 Meril Life Sciences Business Overview
9.8.5 Meril Life Sciences Recent Developments
9.9 Zhonghui Shengxi
9.9.1 Zhonghui Shengxi Biological Hemostatic Material Basic Information
9.9.2 Zhonghui Shengxi Biological Hemostatic Material Product Overview
9.9.3 Zhonghui Shengxi Biological Hemostatic Material Product Market Performance
9.9.4 Zhonghui Shengxi Business Overview
9.9.5 Zhonghui Shengxi Recent Developments
9.10 Beijing Datsing Bio-tech
9.10.1 Beijing Datsing Bio-tech Biological Hemostatic Material Basic Information
9.10.2 Beijing Datsing Bio-tech Biological Hemostatic Material Product Overview
9.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Product Market Performance
9.10.4 Beijing Datsing Bio-tech Business Overview
9.10.5 Beijing Datsing Bio-tech Recent Developments
9.11 Guizhou Jin Jiu Biotech
9.11.1 Guizhou Jin Jiu Biotech Biological Hemostatic Material Basic Information
9.11.2 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Overview
9.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Market Performance
9.11.4 Guizhou Jin Jiu Biotech Business Overview
9.11.5 Guizhou Jin Jiu Biotech Recent Developments
9.12 Beijing Taikesiman
9.12.1 Beijing Taikesiman Biological Hemostatic Material Basic Information
9.12.2 Beijing Taikesiman Biological Hemostatic Material Product Overview
9.12.3 Beijing Taikesiman Biological Hemostatic Material Product Market Performance
9.12.4 Beijing Taikesiman Business Overview
9.12.5 Beijing Taikesiman Recent Developments
9.13 Foryou Medical
9.13.1 Foryou Medical Biological Hemostatic Material Basic Information
9.13.2 Foryou Medical Biological Hemostatic Material Product Overview
9.13.3 Foryou Medical Biological Hemostatic Material Product Market Performance
9.13.4 Foryou Medical Business Overview
9.13.5 Foryou Medical Recent Developments
9.14 Saikesaisi Holdings Group
9.14.1 Saikesaisi Holdings Group Biological Hemostatic Material Basic Information
9.14.2 Saikesaisi Holdings Group Biological Hemostatic Material Product Overview
9.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Product Market Performance
9.14.4 Saikesaisi Holdings Group Business Overview
9.14.5 Saikesaisi Holdings Group Recent Developments
9.15 Biotemed
9.15.1 Biotemed Biological Hemostatic Material Basic Information
9.15.2 Biotemed Biological Hemostatic Material Product Overview
9.15.3 Biotemed Biological Hemostatic Material Product Market Performance
9.15.4 Biotemed Business Overview
9.15.5 Biotemed Recent Developments
9.16 Hangzhou Singclean Medical Products
9.16.1 Hangzhou Singclean Medical Products Biological Hemostatic Material Basic Information
9.16.2 Hangzhou Singclean Medical Products Biological Hemostatic Material Product Overview
9.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Product Market Performance
9.16.4 Hangzhou Singclean Medical Products Business Overview
9.16.5 Hangzhou Singclean Medical Products Recent Developments
10 BIOLOGICAL HEMOSTATIC MATERIAL MARKET FORECAST BY REGION
10.1 Global Biological Hemostatic Material Market Size Forecast
10.2 Global Biological Hemostatic Material Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biological Hemostatic Material Market Size Forecast by Country
10.2.3 Asia Pacific Biological Hemostatic Material Market Size Forecast by Region
10.2.4 South America Biological Hemostatic Material Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biological Hemostatic Material by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biological Hemostatic Material Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biological Hemostatic Material by Type (2025-2030)
11.1.2 Global Biological Hemostatic Material Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biological Hemostatic Material by Type (2025-2030)
11.2 Global Biological Hemostatic Material Market Forecast by Application (2025-2030)
11.2.1 Global Biological Hemostatic Material Sales (K Units) Forecast by Application
11.2.2 Global Biological Hemostatic Material Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biological Hemostatic Material
1.2 Key Market Segments
1.2.1 Biological Hemostatic Material Segment by Type
1.2.2 Biological Hemostatic Material Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICAL HEMOSTATIC MATERIAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biological Hemostatic Material Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biological Hemostatic Material Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICAL HEMOSTATIC MATERIAL MARKET COMPETITIVE LANDSCAPE
3.1 Global Biological Hemostatic Material Sales by Manufacturers (2019-2024)
3.2 Global Biological Hemostatic Material Revenue Market Share by Manufacturers (2019-2024)
3.3 Biological Hemostatic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biological Hemostatic Material Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biological Hemostatic Material Sales Sites, Area Served, Product Type
3.6 Biological Hemostatic Material Market Competitive Situation and Trends
3.6.1 Biological Hemostatic Material Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biological Hemostatic Material Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGICAL HEMOSTATIC MATERIAL INDUSTRY CHAIN ANALYSIS
4.1 Biological Hemostatic Material Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICAL HEMOSTATIC MATERIAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOLOGICAL HEMOSTATIC MATERIAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biological Hemostatic Material Sales Market Share by Type (2019-2024)
6.3 Global Biological Hemostatic Material Market Size Market Share by Type (2019-2024)
6.4 Global Biological Hemostatic Material Price by Type (2019-2024)
7 BIOLOGICAL HEMOSTATIC MATERIAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biological Hemostatic Material Market Sales by Application (2019-2024)
7.3 Global Biological Hemostatic Material Market Size (M USD) by Application (2019-2024)
7.4 Global Biological Hemostatic Material Sales Growth Rate by Application (2019-2024)
8 BIOLOGICAL HEMOSTATIC MATERIAL MARKET SEGMENTATION BY REGION
8.1 Global Biological Hemostatic Material Sales by Region
8.1.1 Global Biological Hemostatic Material Sales by Region
8.1.2 Global Biological Hemostatic Material Sales Market Share by Region
8.2 North America
8.2.1 North America Biological Hemostatic Material Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biological Hemostatic Material Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biological Hemostatic Material Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biological Hemostatic Material Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biological Hemostatic Material Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Johnson and Johnson
9.1.1 Johnson and Johnson Biological Hemostatic Material Basic Information
9.1.2 Johnson and Johnson Biological Hemostatic Material Product Overview
9.1.3 Johnson and Johnson Biological Hemostatic Material Product Market Performance
9.1.4 Johnson and Johnson Business Overview
9.1.5 Johnson and Johnson Biological Hemostatic Material SWOT Analysis
9.1.6 Johnson and Johnson Recent Developments
9.2 BD
9.2.1 BD Biological Hemostatic Material Basic Information
9.2.2 BD Biological Hemostatic Material Product Overview
9.2.3 BD Biological Hemostatic Material Product Market Performance
9.2.4 BD Business Overview
9.2.5 BD Biological Hemostatic Material SWOT Analysis
9.2.6 BD Recent Developments
9.3 Baxter
9.3.1 Baxter Biological Hemostatic Material Basic Information
9.3.2 Baxter Biological Hemostatic Material Product Overview
9.3.3 Baxter Biological Hemostatic Material Product Market Performance
9.3.4 Baxter Biological Hemostatic Material SWOT Analysis
9.3.5 Baxter Business Overview
9.3.6 Baxter Recent Developments
9.4 B.Braun
9.4.1 B.Braun Biological Hemostatic Material Basic Information
9.4.2 B.Braun Biological Hemostatic Material Product Overview
9.4.3 B.Braun Biological Hemostatic Material Product Market Performance
9.4.4 B.Braun Business Overview
9.4.5 B.Braun Recent Developments
9.5 Cura Medical
9.5.1 Cura Medical Biological Hemostatic Material Basic Information
9.5.2 Cura Medical Biological Hemostatic Material Product Overview
9.5.3 Cura Medical Biological Hemostatic Material Product Market Performance
9.5.4 Cura Medical Business Overview
9.5.5 Cura Medical Recent Developments
9.6 GELITA MEDICAL
9.6.1 GELITA MEDICAL Biological Hemostatic Material Basic Information
9.6.2 GELITA MEDICAL Biological Hemostatic Material Product Overview
9.6.3 GELITA MEDICAL Biological Hemostatic Material Product Market Performance
9.6.4 GELITA MEDICAL Business Overview
9.6.5 GELITA MEDICAL Recent Developments
9.7 Curasan AG
9.7.1 Curasan AG Biological Hemostatic Material Basic Information
9.7.2 Curasan AG Biological Hemostatic Material Product Overview
9.7.3 Curasan AG Biological Hemostatic Material Product Market Performance
9.7.4 Curasan AG Business Overview
9.7.5 Curasan AG Recent Developments
9.8 Meril Life Sciences
9.8.1 Meril Life Sciences Biological Hemostatic Material Basic Information
9.8.2 Meril Life Sciences Biological Hemostatic Material Product Overview
9.8.3 Meril Life Sciences Biological Hemostatic Material Product Market Performance
9.8.4 Meril Life Sciences Business Overview
9.8.5 Meril Life Sciences Recent Developments
9.9 Zhonghui Shengxi
9.9.1 Zhonghui Shengxi Biological Hemostatic Material Basic Information
9.9.2 Zhonghui Shengxi Biological Hemostatic Material Product Overview
9.9.3 Zhonghui Shengxi Biological Hemostatic Material Product Market Performance
9.9.4 Zhonghui Shengxi Business Overview
9.9.5 Zhonghui Shengxi Recent Developments
9.10 Beijing Datsing Bio-tech
9.10.1 Beijing Datsing Bio-tech Biological Hemostatic Material Basic Information
9.10.2 Beijing Datsing Bio-tech Biological Hemostatic Material Product Overview
9.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Product Market Performance
9.10.4 Beijing Datsing Bio-tech Business Overview
9.10.5 Beijing Datsing Bio-tech Recent Developments
9.11 Guizhou Jin Jiu Biotech
9.11.1 Guizhou Jin Jiu Biotech Biological Hemostatic Material Basic Information
9.11.2 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Overview
9.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Market Performance
9.11.4 Guizhou Jin Jiu Biotech Business Overview
9.11.5 Guizhou Jin Jiu Biotech Recent Developments
9.12 Beijing Taikesiman
9.12.1 Beijing Taikesiman Biological Hemostatic Material Basic Information
9.12.2 Beijing Taikesiman Biological Hemostatic Material Product Overview
9.12.3 Beijing Taikesiman Biological Hemostatic Material Product Market Performance
9.12.4 Beijing Taikesiman Business Overview
9.12.5 Beijing Taikesiman Recent Developments
9.13 Foryou Medical
9.13.1 Foryou Medical Biological Hemostatic Material Basic Information
9.13.2 Foryou Medical Biological Hemostatic Material Product Overview
9.13.3 Foryou Medical Biological Hemostatic Material Product Market Performance
9.13.4 Foryou Medical Business Overview
9.13.5 Foryou Medical Recent Developments
9.14 Saikesaisi Holdings Group
9.14.1 Saikesaisi Holdings Group Biological Hemostatic Material Basic Information
9.14.2 Saikesaisi Holdings Group Biological Hemostatic Material Product Overview
9.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Product Market Performance
9.14.4 Saikesaisi Holdings Group Business Overview
9.14.5 Saikesaisi Holdings Group Recent Developments
9.15 Biotemed
9.15.1 Biotemed Biological Hemostatic Material Basic Information
9.15.2 Biotemed Biological Hemostatic Material Product Overview
9.15.3 Biotemed Biological Hemostatic Material Product Market Performance
9.15.4 Biotemed Business Overview
9.15.5 Biotemed Recent Developments
9.16 Hangzhou Singclean Medical Products
9.16.1 Hangzhou Singclean Medical Products Biological Hemostatic Material Basic Information
9.16.2 Hangzhou Singclean Medical Products Biological Hemostatic Material Product Overview
9.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Product Market Performance
9.16.4 Hangzhou Singclean Medical Products Business Overview
9.16.5 Hangzhou Singclean Medical Products Recent Developments
10 BIOLOGICAL HEMOSTATIC MATERIAL MARKET FORECAST BY REGION
10.1 Global Biological Hemostatic Material Market Size Forecast
10.2 Global Biological Hemostatic Material Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biological Hemostatic Material Market Size Forecast by Country
10.2.3 Asia Pacific Biological Hemostatic Material Market Size Forecast by Region
10.2.4 South America Biological Hemostatic Material Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biological Hemostatic Material by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biological Hemostatic Material Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biological Hemostatic Material by Type (2025-2030)
11.1.2 Global Biological Hemostatic Material Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biological Hemostatic Material by Type (2025-2030)
11.2 Global Biological Hemostatic Material Market Forecast by Application (2025-2030)
11.2.1 Global Biological Hemostatic Material Sales (K Units) Forecast by Application
11.2.2 Global Biological Hemostatic Material Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biological Hemostatic Material Market Size Comparison by Region (M USD)
Table 5. Global Biological Hemostatic Material Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biological Hemostatic Material Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biological Hemostatic Material Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biological Hemostatic Material Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Hemostatic Material as of 2022)
Table 10. Global Market Biological Hemostatic Material Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biological Hemostatic Material Sales Sites and Area Served
Table 12. Manufacturers Biological Hemostatic Material Product Type
Table 13. Global Biological Hemostatic Material Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biological Hemostatic Material
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biological Hemostatic Material Market Challenges
Table 22. Global Biological Hemostatic Material Sales by Type (K Units)
Table 23. Global Biological Hemostatic Material Market Size by Type (M USD)
Table 24. Global Biological Hemostatic Material Sales (K Units) by Type (2019-2024)
Table 25. Global Biological Hemostatic Material Sales Market Share by Type (2019-2024)
Table 26. Global Biological Hemostatic Material Market Size (M USD) by Type (2019-2024)
Table 27. Global Biological Hemostatic Material Market Size Share by Type (2019-2024)
Table 28. Global Biological Hemostatic Material Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biological Hemostatic Material Sales (K Units) by Application
Table 30. Global Biological Hemostatic Material Market Size by Application
Table 31. Global Biological Hemostatic Material Sales by Application (2019-2024) & (K Units)
Table 32. Global Biological Hemostatic Material Sales Market Share by Application (2019-2024)
Table 33. Global Biological Hemostatic Material Sales by Application (2019-2024) & (M USD)
Table 34. Global Biological Hemostatic Material Market Share by Application (2019-2024)
Table 35. Global Biological Hemostatic Material Sales Growth Rate by Application (2019-2024)
Table 36. Global Biological Hemostatic Material Sales by Region (2019-2024) & (K Units)
Table 37. Global Biological Hemostatic Material Sales Market Share by Region (2019-2024)
Table 38. North America Biological Hemostatic Material Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biological Hemostatic Material Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biological Hemostatic Material Sales by Region (2019-2024) & (K Units)
Table 41. South America Biological Hemostatic Material Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biological Hemostatic Material Sales by Region (2019-2024) & (K Units)
Table 43. Johnson and Johnson Biological Hemostatic Material Basic Information
Table 44. Johnson and Johnson Biological Hemostatic Material Product Overview
Table 45. Johnson and Johnson Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Johnson and Johnson Business Overview
Table 47. Johnson and Johnson Biological Hemostatic Material SWOT Analysis
Table 48. Johnson and Johnson Recent Developments
Table 49. BD Biological Hemostatic Material Basic Information
Table 50. BD Biological Hemostatic Material Product Overview
Table 51. BD Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. BD Business Overview
Table 53. BD Biological Hemostatic Material SWOT Analysis
Table 54. BD Recent Developments
Table 55. Baxter Biological Hemostatic Material Basic Information
Table 56. Baxter Biological Hemostatic Material Product Overview
Table 57. Baxter Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Baxter Biological Hemostatic Material SWOT Analysis
Table 59. Baxter Business Overview
Table 60. Baxter Recent Developments
Table 61. B.Braun Biological Hemostatic Material Basic Information
Table 62. B.Braun Biological Hemostatic Material Product Overview
Table 63. B.Braun Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. B.Braun Business Overview
Table 65. B.Braun Recent Developments
Table 66. Cura Medical Biological Hemostatic Material Basic Information
Table 67. Cura Medical Biological Hemostatic Material Product Overview
Table 68. Cura Medical Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cura Medical Business Overview
Table 70. Cura Medical Recent Developments
Table 71. GELITA MEDICAL Biological Hemostatic Material Basic Information
Table 72. GELITA MEDICAL Biological Hemostatic Material Product Overview
Table 73. GELITA MEDICAL Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GELITA MEDICAL Business Overview
Table 75. GELITA MEDICAL Recent Developments
Table 76. Curasan AG Biological Hemostatic Material Basic Information
Table 77. Curasan AG Biological Hemostatic Material Product Overview
Table 78. Curasan AG Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Curasan AG Business Overview
Table 80. Curasan AG Recent Developments
Table 81. Meril Life Sciences Biological Hemostatic Material Basic Information
Table 82. Meril Life Sciences Biological Hemostatic Material Product Overview
Table 83. Meril Life Sciences Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Meril Life Sciences Business Overview
Table 85. Meril Life Sciences Recent Developments
Table 86. Zhonghui Shengxi Biological Hemostatic Material Basic Information
Table 87. Zhonghui Shengxi Biological Hemostatic Material Product Overview
Table 88. Zhonghui Shengxi Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Zhonghui Shengxi Business Overview
Table 90. Zhonghui Shengxi Recent Developments
Table 91. Beijing Datsing Bio-tech Biological Hemostatic Material Basic Information
Table 92. Beijing Datsing Bio-tech Biological Hemostatic Material Product Overview
Table 93. Beijing Datsing Bio-tech Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Beijing Datsing Bio-tech Business Overview
Table 95. Beijing Datsing Bio-tech Recent Developments
Table 96. Guizhou Jin Jiu Biotech Biological Hemostatic Material Basic Information
Table 97. Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Overview
Table 98. Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Guizhou Jin Jiu Biotech Business Overview
Table 100. Guizhou Jin Jiu Biotech Recent Developments
Table 101. Beijing Taikesiman Biological Hemostatic Material Basic Information
Table 102. Beijing Taikesiman Biological Hemostatic Material Product Overview
Table 103. Beijing Taikesiman Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Beijing Taikesiman Business Overview
Table 105. Beijing Taikesiman Recent Developments
Table 106. Foryou Medical Biological Hemostatic Material Basic Information
Table 107. Foryou Medical Biological Hemostatic Material Product Overview
Table 108. Foryou Medical Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Foryou Medical Business Overview
Table 110. Foryou Medical Recent Developments
Table 111. Saikesaisi Holdings Group Biological Hemostatic Material Basic Information
Table 112. Saikesaisi Holdings Group Biological Hemostatic Material Product Overview
Table 113. Saikesaisi Holdings Group Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Saikesaisi Holdings Group Business Overview
Table 115. Saikesaisi Holdings Group Recent Developments
Table 116. Biotemed Biological Hemostatic Material Basic Information
Table 117. Biotemed Biological Hemostatic Material Product Overview
Table 118. Biotemed Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Biotemed Business Overview
Table 120. Biotemed Recent Developments
Table 121. Hangzhou Singclean Medical Products Biological Hemostatic Material Basic Information
Table 122. Hangzhou Singclean Medical Products Biological Hemostatic Material Product Overview
Table 123. Hangzhou Singclean Medical Products Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Hangzhou Singclean Medical Products Business Overview
Table 125. Hangzhou Singclean Medical Products Recent Developments
Table 126. Global Biological Hemostatic Material Sales Forecast by Region (2025-2030) & (K Units)
Table 127. Global Biological Hemostatic Material Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Biological Hemostatic Material Sales Forecast by Country (2025-2030) & (K Units)
Table 129. North America Biological Hemostatic Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Biological Hemostatic Material Sales Forecast by Country (2025-2030) & (K Units)
Table 131. Europe Biological Hemostatic Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Biological Hemostatic Material Sales Forecast by Region (2025-2030) & (K Units)
Table 133. Asia Pacific Biological Hemostatic Material Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Biological Hemostatic Material Sales Forecast by Country (2025-2030) & (K Units)
Table 135. South America Biological Hemostatic Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Biological Hemostatic Material Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Biological Hemostatic Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Biological Hemostatic Material Sales Forecast by Type (2025-2030) & (K Units)
Table 139. Global Biological Hemostatic Material Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Biological Hemostatic Material Price Forecast by Type (2025-2030) & (USD/Unit)
Table 141. Global Biological Hemostatic Material Sales (K Units) Forecast by Application (2025-2030)
Table 142. Global Biological Hemostatic Material Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biological Hemostatic Material Market Size Comparison by Region (M USD)
Table 5. Global Biological Hemostatic Material Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biological Hemostatic Material Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biological Hemostatic Material Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biological Hemostatic Material Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Hemostatic Material as of 2022)
Table 10. Global Market Biological Hemostatic Material Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biological Hemostatic Material Sales Sites and Area Served
Table 12. Manufacturers Biological Hemostatic Material Product Type
Table 13. Global Biological Hemostatic Material Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biological Hemostatic Material
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biological Hemostatic Material Market Challenges
Table 22. Global Biological Hemostatic Material Sales by Type (K Units)
Table 23. Global Biological Hemostatic Material Market Size by Type (M USD)
Table 24. Global Biological Hemostatic Material Sales (K Units) by Type (2019-2024)
Table 25. Global Biological Hemostatic Material Sales Market Share by Type (2019-2024)
Table 26. Global Biological Hemostatic Material Market Size (M USD) by Type (2019-2024)
Table 27. Global Biological Hemostatic Material Market Size Share by Type (2019-2024)
Table 28. Global Biological Hemostatic Material Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biological Hemostatic Material Sales (K Units) by Application
Table 30. Global Biological Hemostatic Material Market Size by Application
Table 31. Global Biological Hemostatic Material Sales by Application (2019-2024) & (K Units)
Table 32. Global Biological Hemostatic Material Sales Market Share by Application (2019-2024)
Table 33. Global Biological Hemostatic Material Sales by Application (2019-2024) & (M USD)
Table 34. Global Biological Hemostatic Material Market Share by Application (2019-2024)
Table 35. Global Biological Hemostatic Material Sales Growth Rate by Application (2019-2024)
Table 36. Global Biological Hemostatic Material Sales by Region (2019-2024) & (K Units)
Table 37. Global Biological Hemostatic Material Sales Market Share by Region (2019-2024)
Table 38. North America Biological Hemostatic Material Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biological Hemostatic Material Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biological Hemostatic Material Sales by Region (2019-2024) & (K Units)
Table 41. South America Biological Hemostatic Material Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biological Hemostatic Material Sales by Region (2019-2024) & (K Units)
Table 43. Johnson and Johnson Biological Hemostatic Material Basic Information
Table 44. Johnson and Johnson Biological Hemostatic Material Product Overview
Table 45. Johnson and Johnson Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Johnson and Johnson Business Overview
Table 47. Johnson and Johnson Biological Hemostatic Material SWOT Analysis
Table 48. Johnson and Johnson Recent Developments
Table 49. BD Biological Hemostatic Material Basic Information
Table 50. BD Biological Hemostatic Material Product Overview
Table 51. BD Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. BD Business Overview
Table 53. BD Biological Hemostatic Material SWOT Analysis
Table 54. BD Recent Developments
Table 55. Baxter Biological Hemostatic Material Basic Information
Table 56. Baxter Biological Hemostatic Material Product Overview
Table 57. Baxter Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Baxter Biological Hemostatic Material SWOT Analysis
Table 59. Baxter Business Overview
Table 60. Baxter Recent Developments
Table 61. B.Braun Biological Hemostatic Material Basic Information
Table 62. B.Braun Biological Hemostatic Material Product Overview
Table 63. B.Braun Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. B.Braun Business Overview
Table 65. B.Braun Recent Developments
Table 66. Cura Medical Biological Hemostatic Material Basic Information
Table 67. Cura Medical Biological Hemostatic Material Product Overview
Table 68. Cura Medical Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cura Medical Business Overview
Table 70. Cura Medical Recent Developments
Table 71. GELITA MEDICAL Biological Hemostatic Material Basic Information
Table 72. GELITA MEDICAL Biological Hemostatic Material Product Overview
Table 73. GELITA MEDICAL Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GELITA MEDICAL Business Overview
Table 75. GELITA MEDICAL Recent Developments
Table 76. Curasan AG Biological Hemostatic Material Basic Information
Table 77. Curasan AG Biological Hemostatic Material Product Overview
Table 78. Curasan AG Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Curasan AG Business Overview
Table 80. Curasan AG Recent Developments
Table 81. Meril Life Sciences Biological Hemostatic Material Basic Information
Table 82. Meril Life Sciences Biological Hemostatic Material Product Overview
Table 83. Meril Life Sciences Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Meril Life Sciences Business Overview
Table 85. Meril Life Sciences Recent Developments
Table 86. Zhonghui Shengxi Biological Hemostatic Material Basic Information
Table 87. Zhonghui Shengxi Biological Hemostatic Material Product Overview
Table 88. Zhonghui Shengxi Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Zhonghui Shengxi Business Overview
Table 90. Zhonghui Shengxi Recent Developments
Table 91. Beijing Datsing Bio-tech Biological Hemostatic Material Basic Information
Table 92. Beijing Datsing Bio-tech Biological Hemostatic Material Product Overview
Table 93. Beijing Datsing Bio-tech Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Beijing Datsing Bio-tech Business Overview
Table 95. Beijing Datsing Bio-tech Recent Developments
Table 96. Guizhou Jin Jiu Biotech Biological Hemostatic Material Basic Information
Table 97. Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Overview
Table 98. Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Guizhou Jin Jiu Biotech Business Overview
Table 100. Guizhou Jin Jiu Biotech Recent Developments
Table 101. Beijing Taikesiman Biological Hemostatic Material Basic Information
Table 102. Beijing Taikesiman Biological Hemostatic Material Product Overview
Table 103. Beijing Taikesiman Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Beijing Taikesiman Business Overview
Table 105. Beijing Taikesiman Recent Developments
Table 106. Foryou Medical Biological Hemostatic Material Basic Information
Table 107. Foryou Medical Biological Hemostatic Material Product Overview
Table 108. Foryou Medical Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Foryou Medical Business Overview
Table 110. Foryou Medical Recent Developments
Table 111. Saikesaisi Holdings Group Biological Hemostatic Material Basic Information
Table 112. Saikesaisi Holdings Group Biological Hemostatic Material Product Overview
Table 113. Saikesaisi Holdings Group Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Saikesaisi Holdings Group Business Overview
Table 115. Saikesaisi Holdings Group Recent Developments
Table 116. Biotemed Biological Hemostatic Material Basic Information
Table 117. Biotemed Biological Hemostatic Material Product Overview
Table 118. Biotemed Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Biotemed Business Overview
Table 120. Biotemed Recent Developments
Table 121. Hangzhou Singclean Medical Products Biological Hemostatic Material Basic Information
Table 122. Hangzhou Singclean Medical Products Biological Hemostatic Material Product Overview
Table 123. Hangzhou Singclean Medical Products Biological Hemostatic Material Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Hangzhou Singclean Medical Products Business Overview
Table 125. Hangzhou Singclean Medical Products Recent Developments
Table 126. Global Biological Hemostatic Material Sales Forecast by Region (2025-2030) & (K Units)
Table 127. Global Biological Hemostatic Material Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Biological Hemostatic Material Sales Forecast by Country (2025-2030) & (K Units)
Table 129. North America Biological Hemostatic Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Biological Hemostatic Material Sales Forecast by Country (2025-2030) & (K Units)
Table 131. Europe Biological Hemostatic Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Biological Hemostatic Material Sales Forecast by Region (2025-2030) & (K Units)
Table 133. Asia Pacific Biological Hemostatic Material Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Biological Hemostatic Material Sales Forecast by Country (2025-2030) & (K Units)
Table 135. South America Biological Hemostatic Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Biological Hemostatic Material Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Biological Hemostatic Material Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Biological Hemostatic Material Sales Forecast by Type (2025-2030) & (K Units)
Table 139. Global Biological Hemostatic Material Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Biological Hemostatic Material Price Forecast by Type (2025-2030) & (USD/Unit)
Table 141. Global Biological Hemostatic Material Sales (K Units) Forecast by Application (2025-2030)
Table 142. Global Biological Hemostatic Material Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biological Hemostatic Material
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biological Hemostatic Material Market Size (M USD), 2019-2030
Figure 5. Global Biological Hemostatic Material Market Size (M USD) (2019-2030)
Figure 6. Global Biological Hemostatic Material Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biological Hemostatic Material Market Size by Country (M USD)
Figure 11. Biological Hemostatic Material Sales Share by Manufacturers in 2023
Figure 12. Global Biological Hemostatic Material Revenue Share by Manufacturers in 2023
Figure 13. Biological Hemostatic Material Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biological Hemostatic Material Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biological Hemostatic Material Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biological Hemostatic Material Market Share by Type
Figure 18. Sales Market Share of Biological Hemostatic Material by Type (2019-2024)
Figure 19. Sales Market Share of Biological Hemostatic Material by Type in 2023
Figure 20. Market Size Share of Biological Hemostatic Material by Type (2019-2024)
Figure 21. Market Size Market Share of Biological Hemostatic Material by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biological Hemostatic Material Market Share by Application
Figure 24. Global Biological Hemostatic Material Sales Market Share by Application (2019-2024)
Figure 25. Global Biological Hemostatic Material Sales Market Share by Application in 2023
Figure 26. Global Biological Hemostatic Material Market Share by Application (2019-2024)
Figure 27. Global Biological Hemostatic Material Market Share by Application in 2023
Figure 28. Global Biological Hemostatic Material Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biological Hemostatic Material Sales Market Share by Region (2019-2024)
Figure 30. North America Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biological Hemostatic Material Sales Market Share by Country in 2023
Figure 32. U.S. Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biological Hemostatic Material Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biological Hemostatic Material Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biological Hemostatic Material Sales Market Share by Country in 2023
Figure 37. Germany Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biological Hemostatic Material Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biological Hemostatic Material Sales Market Share by Region in 2023
Figure 44. China Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biological Hemostatic Material Sales and Growth Rate (K Units)
Figure 50. South America Biological Hemostatic Material Sales Market Share by Country in 2023
Figure 51. Brazil Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biological Hemostatic Material Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biological Hemostatic Material Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biological Hemostatic Material Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biological Hemostatic Material Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biological Hemostatic Material Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biological Hemostatic Material Market Share Forecast by Type (2025-2030)
Figure 65. Global Biological Hemostatic Material Sales Forecast by Application (2025-2030)
Figure 66. Global Biological Hemostatic Material Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Biological Hemostatic Material
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biological Hemostatic Material Market Size (M USD), 2019-2030
Figure 5. Global Biological Hemostatic Material Market Size (M USD) (2019-2030)
Figure 6. Global Biological Hemostatic Material Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biological Hemostatic Material Market Size by Country (M USD)
Figure 11. Biological Hemostatic Material Sales Share by Manufacturers in 2023
Figure 12. Global Biological Hemostatic Material Revenue Share by Manufacturers in 2023
Figure 13. Biological Hemostatic Material Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biological Hemostatic Material Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biological Hemostatic Material Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biological Hemostatic Material Market Share by Type
Figure 18. Sales Market Share of Biological Hemostatic Material by Type (2019-2024)
Figure 19. Sales Market Share of Biological Hemostatic Material by Type in 2023
Figure 20. Market Size Share of Biological Hemostatic Material by Type (2019-2024)
Figure 21. Market Size Market Share of Biological Hemostatic Material by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biological Hemostatic Material Market Share by Application
Figure 24. Global Biological Hemostatic Material Sales Market Share by Application (2019-2024)
Figure 25. Global Biological Hemostatic Material Sales Market Share by Application in 2023
Figure 26. Global Biological Hemostatic Material Market Share by Application (2019-2024)
Figure 27. Global Biological Hemostatic Material Market Share by Application in 2023
Figure 28. Global Biological Hemostatic Material Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biological Hemostatic Material Sales Market Share by Region (2019-2024)
Figure 30. North America Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biological Hemostatic Material Sales Market Share by Country in 2023
Figure 32. U.S. Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biological Hemostatic Material Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biological Hemostatic Material Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biological Hemostatic Material Sales Market Share by Country in 2023
Figure 37. Germany Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biological Hemostatic Material Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biological Hemostatic Material Sales Market Share by Region in 2023
Figure 44. China Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biological Hemostatic Material Sales and Growth Rate (K Units)
Figure 50. South America Biological Hemostatic Material Sales Market Share by Country in 2023
Figure 51. Brazil Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biological Hemostatic Material Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biological Hemostatic Material Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biological Hemostatic Material Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biological Hemostatic Material Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biological Hemostatic Material Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biological Hemostatic Material Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biological Hemostatic Material Market Share Forecast by Type (2025-2030)
Figure 65. Global Biological Hemostatic Material Sales Forecast by Application (2025-2030)
Figure 66. Global Biological Hemostatic Material Market Share Forecast by Application (2025-2030)
